| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.36▼ | 1.36▼ | 1.37▼ | 1.41▼ | 1.35▲ |
| MA10 | 1.36▼ | 1.37▼ | 1.37▼ | 1.42▼ | 1.30▲ |
| MA20 | 1.37▼ | 1.38▼ | 1.41▼ | 1.38▼ | 1.37▼ |
| MA50 | 1.39▼ | 1.41▼ | 1.42▼ | 1.32▲ | 1.27▲ |
| MA100 | 1.40▼ | 1.41▼ | 1.39▼ | 1.39▼ | 1.34▲ |
| MA200 | 1.39▼ | 1.38▼ | 1.42▼ | 1.29▲ | 1.37▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.001▼ | -0.006▼ | -0.005▼ | -0.002▼ |
| RSI | 46.096▼ | 36.202▼ | 38.223▼ | 48.991▼ | 50.746▲ |
| STOCH | 52.222 | 37.500 | 18.611▼ | 42.566 | 43.803 |
| WILL %R | -66.667 | -75.000 | -90.000▼ | -68.000 | -53.846 |
| CCI | -59.574 | -61.765 | -64.076 | -46.010 | 20.089 |
|
Tuesday, October 27, 2026 06:15 AM
SHELTON, CT / ACCESS Newswire / October 27, 2026 / , Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, explained today that the ...
|
|
Tuesday, October 20, 2026 05:45 AM
The Spreading Ebola Epidemic as well as Mpox Endemic in Africa Disproportionately Impact Children; The Measles Outbreaks Primarily Impact ChildrenSHELTON, CT / ACCESS Newswire / October 20, 2026 / , ...
|
|
Monday, October 19, 2026 07:08 PM
(NYSE American: NNVC) announced positive results from a juvenile mouse study evaluating the safety, tolerability and toxicity of its broad-spectrum antiviral drug NV-387, supporting its potential ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/11/26 | 1.37 | 1.39 | 1.35 | 1.36 | 72,316 |
| 30/10/26 | 1.41 | 1.45 | 1.33 | 1.33 | 214,500 |
| 29/10/26 | 1.4276 | 1.4763 | 1.4276 | 1.43 | 64,807 |
| 28/10/26 | 1.44 | 1.49 | 1.44 | 1.45 | 83,496 |
| 27/10/26 | 1.48 | 1.50 | 1.4007 | 1.46 | 228,096 |
| 26/10/26 | 1.38 | 1.40 | 1.32 | 1.36 | 220,510 |
| 23/10/26 | 1.35 | 1.47 | 1.33 | 1.40 | 159,600 |
| 22/10/26 | 1.46 | 1.53 | 1.38 | 1.39 | 147,100 |
| 21/10/26 | 1.47 | 1.52 | 1.42 | 1.51 | 206,500 |
| 20/10/26 | 1.30 | 1.51 | 1.30 | 1.48 | 463,500 |
|
|
||||
|
|
||||
|
|